Abbott Confirms $448 Million Boost for Irish Diabetes Operation

GALWAY, IRELAND--August 30, 2022--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--U.S. pharmaceutical major Abbott Laboratories (NYSE:ABT) has committed to investing 440 million euro (US$448 million) to grow its Irish operations.

Within this article: Details new Irish investment by Abbott in diabetes operations, new plant, capacity, jobs boost, products produced